These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1211743)

  • 21. [Therapeutic possibilities of nicergoline in neurogenic bladder dysfunction].
    Gallego Gómez J; Jiménez Cruz JF; Martínez Agulló E; Mompó Sanchís JA; Llopis Mínguez B; Boronat Tormo F
    Arch Esp Urol; 1985; 38(2):175-90. PubMed ID: 2862846
    [No Abstract]   [Full Text] [Related]  

  • 22. [Nicergoline and cerebral performance insufficiency. Observations in 1 year treatment controls].
    Kugler J; Heidrich H
    Fortschr Med; 1984 Nov; 102(42):1091-6. PubMed ID: 6392047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of an alpha-adrenergic blocking agent (nicergoline) in the treatment of diabetic angiopathy of lower limbs.
    Calvagno M
    Farmaco Prat; 1982 Jun; 37(6):200-5. PubMed ID: 7106277
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cerebrovascular disorders : facial thermography as a means to evaluate the therapeutic effectiveness of nicergoline].
    Sbarbaro V; Zardini GB; Morgante R; Mora L; Acciarri L; Pistolesi GF
    Farmaco Prat; 1976 Nov; 31(11):549-60. PubMed ID: 1017468
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effectiveness of nicergoline in the treatment of chronic cerebrovascular insufficiency (author's transl)].
    Kaemmerer E
    Nervenarzt; 1980 Jun; 51(6):368-72. PubMed ID: 7453888
    [No Abstract]   [Full Text] [Related]  

  • 26. [Importance of improving sympathetic tonus in the medical treatment of impotence with vascular disorders: clinical and ultrasonic study of the action of nicergoline].
    Chomant J; de Somer-Leroy R; Boismare F; Boquet J; Ozenne G; Schrub JC
    LARC Med; 1982 Sep; 2(8):717-9. PubMed ID: 7162273
    [No Abstract]   [Full Text] [Related]  

  • 27. [Evaluation of the effectiveness and tolerance of the preparation Sermion in the treatment of selected retinal diseases].
    Szaflik J; Jupowiecka A
    Klin Oczna; 1985 Apr; 87(4):165-6. PubMed ID: 3900547
    [No Abstract]   [Full Text] [Related]  

  • 28. [Favorable effect of nicergoline on pruritus in chronic hemodialysis patients. Role of a hyper-alpha-adrenergic system?].
    Rivory JP; Maheut H
    Presse Med; 1984 Dec; 13(44):2703. PubMed ID: 6096843
    [No Abstract]   [Full Text] [Related]  

  • 29. [Failure of nicergoline to control blood pressure in surgery of pheochromocytoma].
    Pinaud M; Arnould JF; Le Neel JC; Rodat O
    Ann Fr Anesth Reanim; 1983; 2(4):327-8. PubMed ID: 6650937
    [No Abstract]   [Full Text] [Related]  

  • 30. [Short-term and long-term results of treatment of chronic arteriopathies of the lower limbs with nicergoline. Importance of intensive medical therapy].
    Quiroli A
    Minerva Cardioangiol; 1980 Dec; 28(12):793-804. PubMed ID: 6111767
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of nicergoline on cerebral blood flow.
    Iliff LD; Du Boulay GH; Marshall J; Russell RW; Symon L
    J Neurol Neurosurg Psychiatry; 1977 Aug; 40(8):746-7. PubMed ID: 925694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapeutic efficacy of nicergoline in ophthalmology. Fluorescence retinographic study (author's transl)].
    Borgioli M; Merendino E; Ricci B
    Arzneimittelforschung; 1979; 29(8a):1311-6. PubMed ID: 540076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rheographic study of nicergolin in the circulation of the lower limbs in healthy and arteriopathic subjects].
    Boismare F; Philippe JC; Leduc X
    Therapie; 1974; 29(6):925-32. PubMed ID: 4618389
    [No Abstract]   [Full Text] [Related]  

  • 34. Animal model of anxiety: effect of nicergoline in the genetically hypertensive rats of Koletsky type and in the rats of Wistar strain.
    Golda V; Petr R
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1989; 32(1):109-20. PubMed ID: 2799259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Haemodynamic and metabolic effects of exercise test in diabetic patients with arteritis treated or not with nicergoline (author's transl)].
    Boismare F; Leclerc JL; Lefrançois J; Moore N; Paux G; Schrub JC; Vuillermet P
    Sem Hop; 1981 Sep 18-25; 57(33-36):1455-7. PubMed ID: 6270809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of sermion in cerebral atherosclerosis patients with a history of ischemic stroke].
    Tsimenko OA; Sosnov IuD; Kharchenko AP; Gaĭduk IuS
    Vrach Delo; 1988 Jul; (7):24-7. PubMed ID: 3188456
    [No Abstract]   [Full Text] [Related]  

  • 37. Animal model of depression: effect of nicotergoline and metergoline.
    Golda V; Petr R
    Act Nerv Super (Praha); 1987 Jun; 29(2):115-7. PubMed ID: 3661096
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapeutic trial in acute cochlear deafness. A comparative study of Ginkgo biloba extract and nicergoline].
    Dubreuil C
    Presse Med; 1986 Sep; 15(31):1559-61. PubMed ID: 2947099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Electroencephalography and psychometric measurements during the treatment of cerebral insufficiency with nicergoline and dihydroergotamine mesylate].
    Kugler JE; Meurer-Krüll BC
    Arzneimittelforschung; 1985; 35(12):1865-70. PubMed ID: 3913425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Nicergoline to reduce intraoperative blood pressure increases in hypertensive patients].
    Muchada R; Lavandier B; Cathignol D; Lamazou J; Haro D; Lucchesi G; Roux MJ
    Cah Anesthesiol; 1985 Nov; 33(7):593-8. PubMed ID: 4092160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.